Shilpa Medicare Ltd. (SHILPAMED) 52 Week High Streak: Second Straight Session at New Peak
- September 4, 2026
- Posted by: Harsh Piplani
- Category: News
Shilpa Medicare Ltd. 52 Week High Streak has now extended to a second straight session, with the stock setting another fresh 52-week high at Rs 974.9. Across the streak, it has moved up 3.68%, while the latest price stood at Rs 962.5. The figures confirm the repeated-high pattern, but they do not establish a company-specific catalyst for the continued move.
As of 04 September 2026 at 9:33 AM IST, the stock traded above its previous close of Rs 955.85 after opening at Rs 963.1 and touching a low of Rs 947.95 during the session. Turnover stood at Rs 1.21 crore and market capitalisation at Rs 18,155.86 crore. For readers, the key difference from a one-day breakout is the repetition: this Shilpa Medicare Ltd. 52 Week High Streak shows the price has kept revisiting new one-year highs, not just reached one once.
Shilpa Medicare Ltd. 52 Week High Streak: Consecutive High Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 962.5 |
| Previous Close | Rs 955.85 |
| Today's Move | +Rs 6.65 (+0.7%) |
| Open | Rs 963.1 |
| High | Rs 974.9 |
| Low | Rs 947.95 |
| Turnover | Rs 1.21 crore |
| Market Capitalisation | Rs 18,155.86 crore |
Shilpa Medicare Ltd. (SHILPAMED) traded at Rs 962.5 versus the previous close of Rs 955.85, a rise of 0.7%. The stock opened at Rs 963.1, reached a high of Rs 974.9 and touched a low of Rs 947.95.
Shilpa Medicare Ltd. traded at Rs 962.5, up Rs 6.65 or 0.7% from the previous close of Rs 955.85. The day’s opening price was Rs 963.1, while the stock touched a high of Rs 974.9 and a low of Rs 947.95. The latest move matters because the high matched the fresh 52-week peak, reinforcing the Shilpa Medicare Ltd. 52 Week High Streak rather than a single isolated print.
The price sat much nearer the day’s high than the low, and that keeps the latest one-year-high reading front and centre for market participants tracking Shilpa Medicare Ltd. Share Price Today. Turnover of Rs 1.21 crore provides a factual activity measure for the session, while market capitalisation of Rs 18,155.86 crore places the company among the larger names in the pharmaceutical space. For a reader comparing Shilpa Medicare Ltd. Stock News with a normal intraday move, the repeated-high pattern is the more important signal than the day’s modest percentage change alone.
What the Repeated 52-Week Highs Show
The repeated highs show that Shilpa Medicare Ltd. has kept setting a new one-year reference point across consecutive trading sessions, with the latest streak now at a second straight session. The cumulative move across the streak is 3.68%, and the fresh peak at Rs 974.9 stands above the latest traded price by Rs 12.4. That gap is useful because it shows where the stock last found acceptance during the session.
The pattern also helps separate a single breakout from a developing streak. In a one-day event, the market sees only the first move beyond the prior high. Here, the stock has already repeated the behaviour on the next session, which is why searches such as Shilpa Medicare Ltd. New One Year High and Shilpa Medicare Ltd. Back to Back 52 Week Highs become relevant. The latest data confirms the price pattern, but it does not identify a fresh company announcement as the driver.
For readers scanning 52 Week High Stocks or Stocks At One Year High Today, this is the type of setup that typically keeps the name under watch. The important point is factual: the stock has continued to register new peaks across two sessions, and the latest move is being recorded against an already elevated base rather than starting from a flat range.
Shilpa Medicare Ltd. (SHILPAMED) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 18,155.86 crore |
| P/E Ratio | 62.88x |
| P/B Ratio | 6.96x |
| ROE | 9.82% |
| ROCE | 11.43% |
| EPS | Rs 15.2 |
| Book Value Per Share | Rs 137.34 |
| Dividend Yield | 0.06% |
Shilpa Medicare Ltd. (SHILPAMED) fundamental metrics show P/E 62.88x, P/B 6.96x, ROE 9.82%, ROCE 11.43%. These figures provide context only and are not a buy or sell signal.
Shilpa Medicare Ltd. has a market capitalisation of Rs 18155.86 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 62.88x, P/B at 6.96x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 9.82% and ROCE of 11.43%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 15.2, book value per share of Rs 137.34, dividend yield of 0.06%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.28x, median ROE of 11.81%, median ROCE of 13.68%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 62.88x |
| Benchmark Median P/E | 32.28x |
| Benchmark Average P/E | 48.75x |
| Benchmark P/E Range | 3.32x to 645.91x |
| Company P/B Ratio | 6.96x |
| Benchmark Median P/B | 2.85x |
| Company ROE | 9.82% |
| Benchmark Median ROE | 11.81% |
| Company ROCE | 11.43% |
| Benchmark Median ROCE | 13.68% |
| Company Market Capitalisation | Rs 18,155.86 crore |
| Benchmark Median Market Cap | Rs 723.58 crore |
Shilpa Medicare Ltd. (SHILPAMED) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Shilpa Medicare Ltd. (SHILPAMED) has a P/E ratio of 62.88x, which is above the benchmark median of 32.28x, a difference of +94.8%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Shilpa Medicare Ltd. (SHILPAMED) has a ROE of 9.82%, which is below the benchmark median of 11.81%, a difference of -16.85%. Shilpa Medicare Ltd. (SHILPAMED) has a ROCE of 11.43%, which is below the benchmark median of 13.68%, a difference of -16.45%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Eris Lifesciences Ltd. | ERIS | 17,918.82 | 28.06 | 4.47 | 19.23 | 14.47 |
| Suven Pharmaceuticals Ltd. | COHANCE | 17,559.3 | 165.73 | 4.57 | 4.02 | 6.12 |
| Glenmark Life Sciences Ltd. | ALIVUS | 17,415.74 | 28.88 | 5 | 18.41 | 24.61 |
| Astrazeneca Pharma India Ltd. | ASTRAZEN | 17,367.38 | 102.39 | 19.21 | 23.02 | 31.24 |
| Alembic Pharmaceuticals Ltd. | APLLTD | 16,239.06 | 22.79 | 2.7 | 12.35 | 11.74 |
Shilpa Medicare Ltd. (SHILPAMED) has a P/E ratio of 62.88x compared with the displayed peer median of 28.88x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 9.82% compares with a peer median of 18.41% across the companies shown in the table. ROCE stood at 11.43% versus the displayed peer median of 14.47%, providing a capital-efficiency comparison. Shilpa Medicare Ltd. (SHILPAMED) has a market capitalisation of Rs 18,155.86 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Shilpa Medicare Ltd.
- The stock has set a fresh 52-week high for the second straight session.
- The cumulative move across the streak is 3.68%.
- The latest peak is Rs 974.9, above the current trading price of Rs 962.5.
- The stock is trading at a P/E of 62.88 and a P/B of 6.96.
- Market capitalisation stands at Rs 18,155.86 crore in the healthcare space.
About Shilpa Medicare Ltd.
Shilpa Medicare Ltd. operates in the Pharmaceuticals & Drugs industry under the Healthcare sector. With a market capitalisation of Rs 18,155.86 crore, it is a sizable listed name in the segment and is tracked closely by investors who follow pharmaceutical share prices, sector valuation and earnings-linked metrics.
The latest numbers show EPS of Rs 15.2, book value of Rs 137.34, ROE of 9.82% and ROCE of 11.43%. Dividend yield is 0.06%. These are the reference points readers typically use when comparing a company’s market price with its business profile, especially during periods when a stock is setting repeated 52-week highs.
Track Shilpa Medicare Ltd. on Univest
Follow Shilpa Medicare Ltd. 52 Week High Streak, Shilpa Medicare Ltd. Share Price and latest stock updates on Univest for a concise view of price, valuation and sector context. You can track the company page for refreshed market data and related stock news as the streak develops.
Visit the Shilpa Medicare Ltd. stock page on Univest for the latest share price, market cap, financial ratios and peer comparison in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Shilpa Medicare Ltd. still hitting 52-week highs?
Ans. The latest figures show that Shilpa Medicare Ltd. has recorded a fresh 52-week high for a second straight session. The data confirms the pattern, but it does not identify a specific company announcement or catalyst behind the repeated highs.
What is the cumulative move in the Shilpa Medicare Ltd. 52 Week High Streak?
Ans. The cumulative move across the current streak is 3.68%. That figure captures the repeated-high pattern across consecutive sessions rather than only the latest day’s percentage change.
How does the current price compare with the latest 52-week high?
Ans. Shilpa Medicare Ltd. last traded at Rs 962.5, while the fresh 52-week high is Rs 974.9. The current price is below that peak by Rs 12.4, which is a useful reference point for readers tracking the streak.
Is Shilpa Medicare Ltd. a 52-week high stock for the second straight session?
Ans. Yes. The stock has now set a fresh 52-week high for the second straight session. That is the core event behind the current Shilpa Medicare Ltd. 52 Week High Streak.
What does the valuation of Shilpa Medicare Ltd. show?
Ans. The stock trades at a P/E of 62.88 and a P/B of 6.96. Both are above the healthcare industry medians in the latest Univest figures, which places the valuation in the premium part of the peer range.
How does Shilpa Medicare Ltd. compare with peers on market capitalisation?
Ans. Shilpa Medicare Ltd. has a market capitalisation of Rs 18,155.86 crore. That places it in a similar band to several listed pharmaceutical peers in the benchmark set, including Eris Lifesciences Ltd. and Glenmark Life Sciences Ltd.
What should investors monitor next in Shilpa Medicare Ltd. stock news?
Ans. Investors can watch whether the stock continues to post new one-year highs, whether the price remains near the latest peak, and whether future company updates change the fundamental backdrop. Those are the key factual monitors during a streak.
Should investors track Shilpa Medicare Ltd. breakthrough levels or only the streak?
Ans. The streak is the starting point, but the broader reading also includes valuation, earnings ratios and sector comparison. For Shilpa Medicare Ltd. Stock News, the repeated highs matter most when read alongside those figures.
Track Shilpa Medicare Ltd. (SHILPAMED) Share Price on Univest
Use Shilpa Medicare Ltd. (SHILPAMED) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
